At the end of the last year, Novouralsk-based Medsintez Plant turned 20 years old. Alexander Petrov, Chairman of the plant's Board of Directors, told Regions of Russia about the impressive successes that the company has achieved over the years and its ambitious plans for the future.
In 2023, the Medsintez Plant, in collaboration with the Promomed Group of Companies, launched the production of a full cycle of hypoglycemic drugs Enligria (liraglutide) and Quincenta (semaglutide) used in treating type II diabetes mellitus, including in patients with obesity and overweight or cardiovascular disease. The preparations are available in the most convenient and familiar for patients dosage form – a disposable prefilled injection and have already been supplied to pharmacies.
Medsintez Plant LLC presented the latest biotechnological developments of pharmaceuticals at the largest international scientific and practical forum in the field of medicine and health care Russian Health Care Week — 2023 held from December 4 to December 8 in Moscow. The main purpose of the Forum is to facilitate the implementation of the national projects “Healthcare” and “Demography”, “Tourism and Hospitality Industry”, the federal project “Development of Medical Services Export”, as well as summarizing the results of the Year of Science and Technology in Medicine.
On September 27, as part of the business program of the GMP conference with international participation, Alexander Petrov, Chairman of the Board of Directors of Medsintez Plant LLC, took part in a Plenary Session on the issues of regulating the circulation of medicines in Russia and the EAEU, developing import independence, and increasing export potential. The session was attended by representatives of the Ministry of Industry and Trade of the Russian Federation, the Minister of Health of the Republic of Nicaragua, the WHO Representative in Russia, a Representative of the Serbian Ministry of Health and other Russian and foreign experts. Mr. Petrov spoke about the problems that Russian pharmaceutical companies face when entering international markets and suggested possible solutions.
Petrov, Alexandr Alexandrovich
Chairman of the Supervisory Board, Chairman of the Board of Directors of Medsintez Plant LLC, Executive Director of the Association of Medical and Pharmaceutical Manufacturers of the Sverdlovsk Region
Karlov, Andrey Alexandrovich
Minister of Health of the Sverdlovsk Region
Charushin, Valery Nikolaevich
Chairman of the Joint Scientific Council for Chemical Sciences, Ural Branch of the Russian Academy of Sciences, Academician of the Russian Academy of Sciences
Donnik, Irina Mikhailovna
Assistant to the President of the National Research Center «Kurchatov Institute», Professor of the Ural State Agrarian University, Federal State Budgetary Educational Institution of Higher Education, Academician of the Russian Academy of Sciences
Kovtun, Olga Petrovna
Rector of the Ural State Medical University, Academician of the Russian Academy of Sciences
Verbitsky, Egor Vladimirovich
Director of the Postovsky Institute of Organic Synthesis, Ural branch of the Russian Academy of Sciences, Doctor of Chemistry, Professor